|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000501 |
To test the feasibility and the efficacy of nutritional interventions in the primary prevention of hypertension in individuals predisposed to the development of hypertension; specifically, to test the hypothesis that reduction of weight and/or decreased sodium intake in obese individuals, or decreased sodium intake with or without increased potassium intake (in men and women, regardless of weight) would prevent the elevation of blood pressure and the incidence of hypertension.
Condition | Intervention | Phase |
Cardiovascular Diseases Heart Diseases Hypertension Obesity Vascular Diseases |
Behavioral: diet, sodium-restricted Behavioral: diet, reducing Drug: potassium |
Phase II |
MedlinePlus related topics: | Heart Diseases High Blood Pressure Obesity Vascular Diseases Weight Control |
Drug Information available for: | Potassium chloride |
Study Type: | Interventional |
Study Design: | Prevention, Randomized |
Ages Eligible for Study: | 25 Years to 49 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Men and women, ages 25 to 49. Diastolic blood pressure between 78 and 89 mm Hg. Free of major disease. Not on a special diet or antihypertensive medication at entry. Some mild to moderately obese subjects.
Investigator: | Nemat Borhani | University of California, Davis |
Investigator: | Robert Jeffery | University of Minnesota |
Investigator: | Herbert Langford | University of Mississippi Medical Center |
Investigator: | Albert Oberman | University of Alabama at Birmingham |
Investigator: | Ronald Prineas | University of Minnesota |
Study ID Numbers: | 20 |
First Received: | October 27, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000501 |
Health Authority: | United States: Federal Government |
|
|
|